Sunday, November 3, 2024
HomeTagsWuXi ATU

WuXi ATU

WuXi ATU Announces Launch of TESSA™ Technology to Improve Scalability and Accessibility of Cell and Gene Therapies

WuXi Advanced Therapies, a wholly owned subsidiary of WuXi AppTec, announced the launch of Tetracycline-Enabled Self-Silencing Adenovirus (TESSA™). This technology is a state-of-the-art novel...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics